Upregulated Expression of SHMT2 Predicts Poor Survival of Lung Adenocarcinoma

Qi Guo; Guang-Hong Huang; Pu Chen; Chao Guo

doi:10.1155/genr/6104753

Genetics Research (Jan 2025)

Upregulated Expression of SHMT2 Predicts Poor Survival of Lung Adenocarcinoma

Qi Guo,
Guang-Hong Huang,
Pu Chen,
Chao Guo

Affiliations

Qi Guo: Department of Surgery
Guang-Hong Huang: Department of Surgery
Pu Chen: Department of Surgery
Chao Guo: Department of Anesthesiology and Surgery

DOI: https://doi.org/10.1155/genr/6104753
Journal volume & issue: Vol. 2025

Abstract

Read online

Conclusions: Our research indicated that elevated SHMT2 expression is strongly linked to adverse clinical characteristics and poor prognosis in LUAD patients. Consequently, SHMT2 may represent a novel prognosis marker and a promising therapeutic target regarding the treatment of LUAD.

Published in Genetics Research

ISSN: 1469-5073 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Science: Biology (General): Genetics
Website: https://onlinelibrary.wiley.com/journal/gr

About the journal